RecruitingNot ApplicableNCT05992324
A Validation Study to Evaluate the Performance of Caption Health Lung Guidance and Interpretation
Sponsor
Caption Health, Inc.
Enrollment
220 participants
Start Date
Jul 17, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to assess the efficacy of Caption LungAI.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Patients over the age of 18
- Patients presenting to the hospital or outpatient setting with shortness of breath and suspected B-lines.
Exclusion Criteria1
- Patients in extremis/in whom a research lung ultrasound would not normally be performed due to other priorities
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICECaption LungAI
Caption LungAI is a software that is designed to help non-expert healthcare professionals acquire diagnostic quality images on an 8-zone lung protocol for both healthy patients and patients presenting with pathology such as B-Lines.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05992324
Related Trials
Effectiveness of a Mastery Learning Education Program for Parents of Children Using Inhaler Therapy in an Emergency Unit
NCT074527311 location
Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea
NCT065543531 location
Determinants of Cardiorespiratory Fitness and Effects of HIIT in Patients With ANOCA Obstructive Coronary Artery Disease(ANOCA)
NCT071829551 location
Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents
NCT062014941 location